Descriptor English: | Clavulanic Acid | ||||||
Descriptor Spanish: |
Ácido Clavulánico
| ||||||
Descriptor Portuguese: | Ácido Clavulânico | ||||||
Descriptor French: | Acide clavulanique | ||||||
Entry term(s): |
BRL 14151 BRL-14151 BRL14151 Clavulanate Clavulanate Potassium Clavulanate, Potassium Clavulanate, Sodium Clavulanic Acid, Monopotassium Salt Clavulanic Acid, Monosodium Salt MM 14151 MM-14151 MM14151 Potassium Clavulanate Potassium, Clavulanate Sodium Clavulanate |
||||||
Tree number(s): |
D02.065.589.099.374.160 D03.633.100.300.374.160 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D019818 | ||||||
Scope note: | A beta-lactam antibiotic produced by the actinobacterium Streptomyces clavuligerus. It is a suicide inhibitor of bacterial beta-lactamase enzymes. Administered alone, it has only weak antibacterial activity against most organisms, but given in combination with other beta-lactam antibiotics it prevents antibiotic inactivation by microbial lactamase. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Entry Combination: |
analogs & derivatives:Clavulanic Acids
|
||||||
Pharm Action: |
beta-Lactamase Inhibitors |
||||||
Registry Number: | 23521W1S24 | ||||||
CAS Type 1 Name: | 4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, (2R-(2alpha,3Z,5alpha)) | ||||||
Previous Indexing: |
Clavulanic Acids (1978-1997) Lactams (1976-1982) |
||||||
Public MeSH Note: | 98; CLAVULANIC ACID was indexed under CLAVULANIC ACIDS 1978-97 & LACTAMS 1976-82 |
||||||
History Note: | 98; use CLAVULANIC ACID (NM) 1980-97 |
||||||
DeCS ID: | 33383 | ||||||
Unique ID: | D019818 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1998/01/01 | ||||||
Date of Entry: | 1997/06/20 | ||||||
Revision Date: | 2018/06/29 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Clavulanic Acid
- Preferred
MM-14151
- Narrower
Clavulanate Potassium
- Narrower
Clavulanic Acid, Monosodium Salt
- Narrower
BRL-14151
- Narrower
Clavulanate
- Narrower
Concept UI |
M0029416 |
Scope note | A beta-lactam antibiotic produced by the actinobacterium Streptomyces clavuligerus. It is a suicide inhibitor of bacterial beta-lactamase enzymes. Administered alone, it has only weak antibacterial activity against most organisms, but given in combination with other beta-lactam antibiotics it prevents antibiotic inactivation by microbial lactamase. |
Preferred term | Clavulanic Acid |
Concept UI |
M0372714 |
Preferred term | MM-14151 |
Entry term(s) |
MM 14151 MM14151 |
Concept UI |
M0329136 |
Preferred term | Clavulanate Potassium |
Entry term(s) |
Clavulanate, Potassium Clavulanic Acid, Monopotassium Salt Potassium Clavulanate Potassium, Clavulanate |
Concept UI |
M0329135 |
Preferred term | Clavulanic Acid, Monosodium Salt |
Entry term(s) |
Clavulanate, Sodium Sodium Clavulanate |
Concept UI |
M0372715 |
Preferred term | BRL-14151 |
Entry term(s) |
BRL 14151 BRL14151 |
Concept UI |
M0372713 |
Preferred term | Clavulanate |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey